Study of nanoformulations for breast cancer treatment

Breast cancer is the leading cause of cancer incidence worldwide and the fifth leading cause of cancer deaths worldwide. Currently available therapies have many limitations, while targeting, concentration control, heterogeneity and drug resistance remain the biggest obstacles to successful treatment of breast cancer. The application of nanoformulations to breast cancer treatment can enhance the efficacy of therapy by addressing these obstacles. In this review article, we briefly introduce the shortcomings of current breast cancer treatment methods, as well as nanoformulations as a developing breast cancer treatment method, including enhancing the targeting of drugs through active and passive targeting of nanoformulations, stabilizing the drug treatment window through slow release of drugs, and the application of nanoformulations in the integration of diagnosis and treatment. In the coming years, nanotechnology is expected to lead to more effective treatment options for breast cancer patients, improving patient survival and quality of life.